Drawing for WIZMI

USPTO serial 98678038

WIZMI

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
IP, KENNINA NGA-YU
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with WIZMI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jacqueline Zion

Jacqueline Zion Pearl Cohen LLP7 Times Square, 19th FlNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable big data analysis and management computer software and hardware for monitoring, tracking, recording, storing, managing, displaying and analyzing medical parameters, signs, symptoms, conditions, and medical data in the nature of the concentration of pharmaceuticals, chemicals and proteins in the blood, glucose, blood lipids, pulse, and blood pressure; downloadable computer application software for all devices with Internet access, namely, mobile phones, portable media players, handheld computers, PCs, laptop, tablets, namely, software for monitoring, tracking, recording, storing, managing, displaying and analyzing medical parameters, signs, symptoms, conditions, and medical data in the nature of the concentration of pharmaceuticals, chemicals and proteins in the blood, glucose, blood lipids, pulse, and blood pressure by means of a global computer networkACTIVE—
010Medical devices, namely, wearable medical sensor apparatus to gather biometric data for medical use, namely, devices to be used during day-to-day activities and comprised primarily of non-invasive medical sensors, and also including receivers, sensor housings, processing and communication unit and embedded downloadable software, all sold as a unit and used for monitoring, tracking, recording, storing, managing, displaying and analyzing medical parameters, signs, symptoms, conditions, and medical data in the nature of the concentration of pharmaceuticals, chemicals and proteins in the blood, glucose, blood lipids, pulse, and blood pressureACTIVE—
042Software as a service (SAAS) services featuring an online non-downloadable Internet-based computer software and application for continuous monitoring of, tracking, analyzing, displaying, predicting and storing medical parameters, signs, symptoms, conditions, and medical data in the nature of the concentration of pharmaceuticals, chemicals and proteins in the blood, glucose, blood lipids, pulse, and blood pressure; providing temporary use of on-line non-downloadable cloud computing software for monitoring, tracking, recording, storing, managing, displaying and analyzing medical parameters, signs, symptoms, conditions, and medical data in the nature of the concentration of pharmaceuticals, chemicals and proteins in the blood, glucose, blood lipids, pulse, and blood pressure, during day to day activities all for use in connection with a cloud-based data management platform and online software tools for big data analytics; technical support in the nature of troubleshooting of computer software problems, and upgrading, repair and maintenance of computer software applicationsACTIVE—
044Telemedicine services and medical services; Medical services, namely, medical analysis services and analyzing statistical health data relating to medical parameters, signs, symptoms, conditions and data, for diagnosis and treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 14, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 13, 2026EX1GSOU EXTENSION 1 GRANTED—
Jul 13, 2026EXT1SOU EXTENSION 1 FILED—
Jul 13, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 10, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 10, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 10, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 10, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 13, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 18, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 18, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 12, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 17, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 17, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Oct 17, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 17, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 17, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
May 21, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 21, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 21, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 7, 2025DOCKASSIGNED TO EXAMINER—
Jan 22, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 1, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance